Stat3 promotes IL-10 expression in lupus T cells through trans-activation and chromatin remodeling

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 37, 2014, Pages 13457-13462

  Hedrich, Christian M ^a,b   Rauen, Thomas ^a,c   Apostolidis, Sokratis A ^a   Grammatikos, Alexandros P ^a   Rodriguez, Noe Rodriguez ^a   Ioannidis, Christina ^a   Kyttaris, Vasileios C ^a   Crispin, Jose C ^a   Tsokos, George C ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

E1A ASSOCIATED P300 PROTEIN; EP300 PROTEIN, HUMAN; HISTONE; INTERLEUKIN 10; LYMPHOCYTE ANTIGEN RECEPTOR; LYSINE; PROTEIN BINDING; STAT3 PROTEIN; STAT5 PROTEIN;

ACETYLATION; BIOLOGY; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA METHYLATION; ENHANCER REGION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TRANSCRIPTION INITIATION;

ACETYLATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; COMPUTATIONAL BIOLOGY; DNA METHYLATION; E1A-ASSOCIATED P300 PROTEIN; ENHANCER ELEMENTS, GENETIC; HISTONES; HUMANS; INTERLEUKIN-10; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYSINE; PHOSPHORYLATION; PROTEIN BINDING; RECEPTORS, ANTIGEN, T-CELL; STAT3 TRANSCRIPTION FACTOR; STAT5 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; TRANSCRIPTIONAL ACTIVATION;

EID: 84907190280     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1408023111     Document Type: Article

References (36)

1. Hedrich CM, Bream JH (2010) Cell type-specific regulation of IL-10 expression in inflammation and disease. Immunol Res 47(1-3):185-206.
2. Hofmann SR, Rösen-Wolff A, Tsokos GC, Hedrich CM (2012) Biological properties and regulation of IL-10 related cytokines and their contribution to autoimmune disease and tissue injury. Clin Immunol 143(2):116-127.
3. Peng H, et al. (2013) Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus. Clin Rheumatol 32(9):1255-1266.
4. Tsokos GC (2011) Systemic lupus erythematosus. N Engl J Med 365(22):2110-2121.
5. Houssiau FA, et al. (1995) Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus 4(5):393-395.
6. Enghard P, Langnickel D, Riemekasten G (2006) T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis. Scand J Rheumatol 35(3):209-216.
7. Mellor-Pita S, et al. (2009) Monocytes and T lymphocytes contribute to a predominance of interleukin 6 and interleukin 10 in systemic lupus erythematosus. Cytometry B Clin Cytom 76(4):261-270.
8. Zhao M, et al. (2010) Hypomethylation of IL10 and IL13 promoters in CD4+ T cells of patients with systemic lupus erythematosus. J Biomed Biotechnol 2010:931018.
9. Koenig KF, et al. (2012) Serum cytokine profile in patients with active lupus nephritis. Cytokine 60(2):410-416.
10. Tsuji-Takayama K, et al. (2008) The production of IL-10 by human regulatory T cells is enhanced by IL-2 through a STAT5-responsive intronic enhancer in the IL-10 locus. J Immunol 181(6):3897-3905.
11. Grant LR, et al. (2008) Stat4-dependent, T-bet-independent regulation of IL-10 in NK cells. Genes Immun 9(4):316-327.
12. Lauwerys BR, Garot N, Renauld JC, Houssiau FA (2000) Interleukin-10 blockade corrects impaired in vitro cellular immune responses of systemic lupus erythematosus patients. Arthritis Rheum 43(9):1976-1981.
13. Llorente L, et al. (2000) Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum 43(8):1790-1800.
14. Apostolidis SA, Crispín JC, Tsokos GC (2011) IL-17-producing T cells in lupus nephritis. Lupus 20(2):120-124.
15. Apostolidis SA, et al. (2011) The dysregulation of cytokine networks in systemic lupus erythematosus. J Interferon Cytokine Res 31(10):769-79.
16. Rauen T, Hedrich CM, Tenbrock K, Tsokos GC (2013) cAMP responsive element modulator: A critical regulator of cytokine production. Trends Mol Med 19(4):262-269.
17. +T cells of lupus nephritis patients. Clin Exp Immunol 165(2):163-171.
18. Llorente L, et al. (1995) Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 181(3): 839-844.
19. Harada T, et al. (2007) Increased expression of STAT3 in SLE T cells contributes to enhanced chemokine-mediated cell migration. Autoimmunity 40(1):1-8.
20. Pflegerl P, et al. (2009) Epidermal loss of JunB leads to a SLE phenotype due to hyper IL-6 signaling. Proc Natl Acad Sci USA 106(48):20423-20428.
21. Hale MB, Krutzik PO, Samra SS, Crane JM, Nolan GP (2009) Stage dependent aberrant regulation of cytokine-STAT signaling in murine systemic lupus erythematosus. PLoS ONE 4(8):e6756.
22. Huang X, Guo Y, Bao C, Shen N (2011) Multidimensional single cell based STAT phosphorylation profiling identifies a novel biosignature for evaluation of systemic lupus erythematosus activity. PLoS ONE 6(7):e21671.
23. Crispín JC, Tsokos GC (2009) Transcriptional regulation of IL-2 in health and autoimmunity. Autoimmun Rev 8(3):190-195.
24. Hedrich CM, et al. (2012) cAMP response element modulator alpha controls IL2 and IL17A expression during CD4 lineage commitment and subset distribution in lupus. Proc Natl Acad Sci USA 109(41):16606-16611.
25. Hedrich CM, Rauen T, Tsokos GC (2011) cAMP-responsive element modulator (CREM)α protein signaling mediates epigenetic remodeling of the human interleukin-2 gene: implications in systemic lupus erythematosus. J Biol Chem 286(50):43429-43436.
26. Bethunaickan R, Berthier CC, Zhang W, Kretzler M, Davidson A (2013) Comparative transcriptional profiling of 3 murine models of SLE nephritis reveals both unique and shared regulatory networks. PLoS ONE 8(10):e77489.
27. Chen Z, O'Shea JJ (2008) Th17 cells: A new fate for differentiating helper T cells. Immunol Res 41(2):87-102.
28. Korn T, Bettelli E, Oukka M, Kuchroo VK (2009) IL-17 and Th17 Cells. Annu Rev Immunol 27:485-517.
29. Ballestar E (2011) An introduction to epigenetics. Adv Exp Med Biol 711:1-11.
30. Hedrich CM, Tsokos GC (2011) Epigenetic mechanisms in systemic lupus erythematosus and other autoimmune diseases. Trends Mol Med 17(12):714-724.
31. Costa-Reis P, Sullivan KE (2013) Genetics and epigenetics of systemic lupus erythematosus. Curr Rheumatol Rep 15(9):369.
32. Zhang Y, Zhao M, Sawalha AH, Richardson B, Lu Q (2013) Impaired DNA methylation and its mechanisms in CD4(+)T cells of systemic lupus erythematosus. J Autoimmun 41:92-99.
33. Hedrich CM, et al. (2010) Dynamic DNA methylation patterns across the mouse and human IL10 genes during CD4+ T cell activation: Influence of IL-27. Mol Immunol 48(1-3):73-81.
34. Paulson M, et al. (1999) Stat protein transactivation domains recruit p300/CBP through widely divergent sequences. J Biol Chem 274(36):25343-25349.
35. Pfitzner E, Jähne R, Wissler M, Stoecklin E, Groner B (1998) p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response. Mol Endocrinol 12(10):1582-1593.
36. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725.